MYC and lung adenocarcinoma: Furthermore, MYC amplification was described as a poor prognostic marker of early stage adenocarcinomas of the lung [16] as well as MYC gain determined by fluorescence in situ hybridization was shown to be an independent poor prognostic factor for disease-free survival and overall survival in lung adenocarcinomas [17].